These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 36499042)

  • 1. Autoimmune Diseases Affecting Hemostasis: A Narrative Review.
    Favaloro EJ; Pasalic L; Lippi G
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
    Arnout J
    Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Advances in Anticoagulant Treatment of Immune Thrombosis: A Focus on Direct Oral Anticoagulants in Heparin-Induced Thrombocytopenia and Anti-Phospholipid Syndrome.
    Carré J; Jourdi G; Gendron N; Helley D; Gaussem P; Darnige L
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How I treat anticoagulant-refractory thrombotic antiphospholipid syndrome.
    Cohen H; Isenberg DA
    Blood; 2021 Jan; 137(3):299-309. PubMed ID: 32898856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical issues in hematology: anemia, thrombocytopenia, coagulopathy, and blood product transfusions in critically ill patients.
    Drews RE
    Clin Chest Med; 2003 Dec; 24(4):607-22. PubMed ID: 14710693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiphospholipid Syndrome and Cardiac Bypass: The Careful Balance between Clotting and Bleeding.
    Ural K; Edelson J
    J Extra Corpor Technol; 2021 Mar; 53(1):46-49. PubMed ID: 33814605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel mechanism of thrombosis in antiphospholipid antibody syndrome.
    Vlachoyiannopoulos PG; Routsias JG
    J Autoimmun; 2010 Nov; 35(3):248-55. PubMed ID: 20638238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bleeding in the antiphospholipid syndrome.
    Forastiero R
    Hematology; 2012 Apr; 17 Suppl 1():S153-5. PubMed ID: 22507807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antiphospholipid syndrome: from pathophysiology to treatment.
    Negrini S; Pappalardo F; Murdaca G; Indiveri F; Puppo F
    Clin Exp Med; 2017 Aug; 17(3):257-267. PubMed ID: 27334977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between Antiphospholipid Antibodies and Protein C Anticoagulant Pathway: A Narrative Review.
    Pengo V
    Semin Thromb Hemost; 2022 Nov; 48(8):971-977. PubMed ID: 35021251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bleeding and thrombosis in a patient with secondary antiphospholipid syndrome.
    Kaaroud H; Beji S; Guermazi S; Moussa FB; Hamida FB; Ezzine S; Abdallah TB; El Younsi F; Kheder A
    Saudi J Kidney Dis Transpl; 2008 Mar; 19(2):227-31. PubMed ID: 18310872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiphospholipid syndrome - an update.
    Linnemann B
    Vasa; 2018 Oct; 47(6):451-464. PubMed ID: 30205764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What is the appropriate anticoagulation strategy for thrombotic antiphospholipid syndrome?
    Arachchillage DRJ; Laffan M
    Br J Haematol; 2020 Apr; 189(2):216-227. PubMed ID: 32108324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Antiphospholipid Syndrome in the Pediatric Population.
    Sloan EE; McCurdy D
    Adv Pediatr; 2022 Aug; 69(1):107-121. PubMed ID: 35985703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What causes the antiphospholipid syndrome?
    Merrill JT
    Curr Rheumatol Rep; 2001 Aug; 3(4):293-300. PubMed ID: 11470047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Following 90 patients with antiphospholipid syndrome with antibody titers and correlations with clinical manifestations: symptoms of the disease, a new antibody and correlations with clinical manifestations in the Israeli population].
    Marai I; Levi Y; Godard G; Shoenfeld Y
    Harefuah; 2001 Jun; 140(6):495-500, 565. PubMed ID: 11420848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antiphospholipid syndrome. Pathogenesis, molecular basis and clinical aspects].
    von Landenberg P; von Landenberg C; Schölmerich J; Lackner KJ
    Med Klin (Munich); 2001 Jun; 96(6):331-42. PubMed ID: 11450585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiphospholipid Antibody-Mediated Thrombotic Mechanisms in Antiphospholipid Syndrome: Towards Pathophysiology-Based Treatment.
    Islam MA; Alam F; Sasongko TH; Gan SH
    Curr Pharm Des; 2016; 22(28):4451-69. PubMed ID: 27229722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrointestinal symptoms as the first manifestation of antiphospholipid syndrome.
    Zou X; Fan Z; Zhao L; Xu W; Zhang J; Jiang Z
    BMC Gastroenterol; 2021 Apr; 21(1):148. PubMed ID: 33794795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome.
    Bala MM; Celinska-Lowenhoff M; Szot W; Padjas A; Kaczmarczyk M; Swierz MJ; Undas A
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD012169. PubMed ID: 33045766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.